Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,664 | -41,789 | -31,127 | N/A | N/A |
| Depreciation Amortization | 2,892 | 1,764 | 1,188 | N/A | N/A |
| Income taxes - deferred | -4,373 | N/A | N/A | N/A | N/A |
| Accounts receivable | -1,434 | -7,303 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,264 | 109 | 1,968 | N/A | N/A |
| Other Working Capital | -4,455 | 38,061 | 4,650 | N/A | N/A |
| Other Operating Activity | 154 | 10,371 | -1,827 | 0 | 0 |
| Operating Cash Flow | $-49,616 | $1,213 | $-25,148 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -105,576 | N/A | N/A | N/A | N/A |
| PPE Investments | 3,607 | -1,499 | -1,575 | N/A | N/A |
| Net Acquisitions | N/A | 160 | N/A | N/A | N/A |
| Investing Cash Flow | $-101,969 | $-1,339 | $-1,575 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 277 | 420 | 74 | N/A | N/A |
| Common Stock Repurchased | -45 | -131 | N/A | N/A | N/A |
| Other Financing Activity | 98,426 | 60,558 | 22,588 | 0 | 0 |
| Financing Cash Flow | $98,658 | $60,847 | $22,662 | $N/A | $N/A |
| Beginning Cash Position | 69,800 | 9,079 | 13,140 | N/A | N/A |
| End Cash Position | 16,873 | 69,800 | 9,079 | N/A | N/A |
| Net Cash Flow | $-52,927 | $60,721 | $-4,061 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,616 | 1,213 | -25,148 | N/A | N/A |
| Capital Expenditure | -2,589 | -1,499 | -1,575 | N/A | N/A |
| Free Cash Flow | -52,205 | -286 | -26,723 | 0 | 0 |